J&J fights back and loses $302 million settlement for Pelvic Mesh Business

Published Date: 02 Mar 2023

On Tuesday, the United States Supreme Court announced a $302 million judgment against Johnson & Johnson in a lawsuit brought by the state of California alleging Johnson & Johnson covered up the dangers of birth control products. .

Read Full News

Latest News

Ask the HF Expert: Guideline-Directed Medical Therapy

Chief Cardiology fellow Yash Varma asks HF expert Ileana Piña for tips on when patients are stable to discharge on guideline-directed medical therapy and if it’s ever ok to de-escalate.

Do Smokers Need to Quit Before Lung Cancer Surgery?

Patients who still smoke heading into lung cancer surgery have a higher complication rate than those who have quit — but their mortality risk is no different, a large retrospective study finds.

Adrian Harris: Why Oncology Must Look Beyond Cancer Cells

Many promising therapies fail because of poor patient selection; Harris warns that only about one third of tumors are truly hypoxic, underscoring the need for precise biomarkers in trials.

‘Impossible’ Now Possible: Making Brain Tissue Transparent

Researchers used a blood protein wash to render brain tissue transparent down to 700 µm, witnessing live-firing activity without killing a single neuron.

AstraZeneca's Imfinzi With Pre-surgery Drug Boosts Survival in Bladder Cancer Trial

AstraZeneca said on Thursday that a late-stage trial of Imfinzi, ⁠combined with a targeted therapy prior to a surgery, showed significantly ⁠improved survival rate in...

STS: Society of Thoracic Surgeons

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Latest News

Chief Cardiology fellow Yash Varma asks HF expert Ileana Piña for tips on when patients are stable to discharge on guideline-directed medical therapy and if it’s ever ok to de-escalate.

Patients who still smoke heading into lung cancer surgery have a higher complication rate than those who have quit — but their mortality risk is no different, a large retrospective study finds.

Many promising therapies fail because of poor patient selection; Harris warns that only about one third of tumors are truly hypoxic, underscoring the need for precise biomarkers in trials.

Researchers used a blood protein wash to render brain tissue transparent down to 700 µm, witnessing live-firing activity without killing a single neuron.

AstraZeneca said on Thursday that a late-stage trial of Imfinzi, ⁠combined with a targeted therapy prior to a surgery, showed significantly ⁠improved survival rate in...

News All Time

Anti-TNF May Reduce Kidney Injury in Brain Death Donors

Researchers identify TNF driven injury pathways in brain death donors and test anti-TNF therapy to improve kidney graft quality before transplantation.

FDA Flags Shortage Of Neurosurgical Pads and Sponges

The U.S. Food and Drug Administration on Wednesday acknowledged ongoing supply disruptions of certain ⁠sterile pads, sponges and strips used in neurosurgery, warning the...

Ask the HF Expert: Managing Congestion

Chief fellow Yash Varma asks heart failure expert Ileana Piña for her tips and tricks in managing patients admitted with acute decompensated heart failure.

UK and US Set Path to Shared Medical Device Approvals

The MHRA and FDA have agreed to explore mutual recognition of medical device approvals, in a move that could cut delays for patients in both countries.

They Say Compassion Drains You. Science Disagrees

Research suggests it’s not compassion that wears doctors down but a different emotion — a distinction that may help them recharge more effectively.

You Haven’t Aged a Day: The Prognostic Value of Facial Aging

An AI study suggests that the rate of facial aging could be a biomarker for cancer mortality.

Intraoperative Irradiation Safe for Breast Cancer Relapse

Intraoperative reirradiation in combination with a second breast-conserving surgery is safe and well tolerated in patients with late local recurrence of breast cancer.

Pancreatic Cancer: Should Surgery or Chemo Come First?

There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with operable pancreatic cancer. Here’s what we know.

Surgical Robots: NHS Ambition Outpacing Delivery

RCS England finds no national strategy for funding or distributing surgical robots, leaving some hospitals reliant on local fundraising.

NDAs Are Illegal in Healthcare, Says Ethicist

Ethicist Art Caplan discusses nondisclosure agreements in healthcare.

Whole-Body MRI Predicts Surgery Outcomes in Ovarian Cancer

Whole-body diffusion-weighted MRI accurately predicts complete resection and survival outcomes after neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

MRI Sharpens Prostate Cancer Risk Stratification

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to standard prognostic models to inform subsequent treatment.

Minimally Invasive Ablation Can Treat Small Kidney Tumors

Less invasive ablation treatment in patients with small renal tumors has a comparable risk for tumor progression to surgical resection, with fewer complications and shorter hospital stays.

177Lu-PSMA-617 Delays Progression in Prostate Cancer

177Lu-PSMA-617 delays disease progression at a significantly higher rate than standard of care in patients with oligometastatic hormone-sensitive prostate cancer.

Does ART Match ALND After Neoadjuvant Breast Cancer Therapy?

After neoadjuvant breast cancer treatment, axillary radiotherapy may offer an effective alternative to axillary lymph node dissection.

Recommended News For You

What is a "cancer vaccine" and is it the same as a COVID vaccine?

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

A new theranostic drug targets different cancer types.

Congress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

Alkem introduces cetuximab under the trade name Cetuxa in India.

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Recommended Articles For You

Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review 

The Digital Biopsy: How Artificial Intelligence is Redefining Cancer Pathology? 

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective 

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Positive Survival Data in Lung Cancer With Perioperative Therapy

2.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

3.

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

4.

For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.

5.

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

1.

Case Study: Artificial Intelligence in Early Cancer Detection

2.

Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment

3.

What is Mullerian and How Does it Affect Your Health

4.

AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies

5.

Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Should We Use DARA Up Front As First-Line Therapy in MM?

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot